Literature DB >> 2460536

Study of the epitope structure of purified Dac G I and Lol p I, the major allergens of Dactylis glomerata and Lolium perenne pollens, using monoclonal antibodies.

W Mourad1, S Mécheri, G Peltre, B David, J Hébert.   

Abstract

The use of mAb allowed us to further analyze the cross-reactivity between purified Dac g I and Lol p I, the major allergens of Dactylis glomerata (cocksfoot) and Lolium perenne (Rye grass), respectively. It was first shown, using IEF, followed by immunoprinting, that serum IgE antibodies from most grass-sensitive patients recognize both Dac g I and Lol p I. Second, three different anti-Lol p I mAb, 290A-167, 348A-6, and 539A-6, and one anti-Dac g I mAb, P3B2 were all shown to react with Dac g I and Lol p I, indicating that the two molecules share common epitopes. Epitope specificity of the mAb was determined by competitive binding inhibition of a given labeled mAb to solid phase fixed Dac g I or Lol p I by the mAb. The results indicated that the four mAb are directed against four different and non-overlapping epitopes present on both allergens. Using double-binding RIA, our data strongly suggest that the common epitopes are not repetitive on both molecules. In addition to their similar physicochemical characteristics, such as isolectric points and m.w., Dac g I and Lol p I share four identical epitopes. Binding inhibition of human IgE to Lol p I and Dac g I by the mAb was also assessed. The results indicated that each mAb was able to inhibit such reactions to variable degree but no additive inhibition was observed when two mAb of different specificities were used in combination, suggesting that the human IgE binding site is partially shared by each epitope recognized by the four mAb.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460536

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Epitope specificity of IgE antibodies to a major allergen (Cry j 1) of Japanese cedar pollen in sera of humans and monkeys with pollinosis.

Authors:  M Sakaguchi; M Hashimoto; H Nigi; H Yasueda; Y Takahashi; M Watanabe; T Nagoya; Y Taniguchi; M Kurimoto; S Inouye
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Aerial pollen diversity in India and their clinical significance in allergic diseases.

Authors:  A B Singh; Pawan Kumar
Journal:  Indian J Clin Biochem       Date:  2004-07

3.  Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy.

Authors:  A M Roberts; R Van Ree; S M Cardy; L J Bevan; M R Walker
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

4.  Modulation of immune response to Lol p I by pretreatment with anti-idiotypic antibody is not restricted to the idiotypic expression.

Authors:  Y Boutin; J Hébert
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  Detection of auto-anti-idiotypic antibodies to Lol p I (rye I) IgE antibodies in human sera by the use of murine idiotypes: levels in atopic and non-atopic subjects and effects of immunotherapy.

Authors:  J Hébert; D Bernier; W Mourad
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

6.  An aerobiological perspective in allergy and asthma.

Authors:  Anand Bahadur Singh; Chandni Mathur
Journal:  Asia Pac Allergy       Date:  2012-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.